太费时间了,找到这个供参考。在这里规则是要遵守的,不然执照不保。

来源: 2023-01-19 03:49:22 [旧帖] [给我悄悄话] 本文已被阅读:

Once you’ve been ill with the virus for more than a week, the damage done to the body in a severe case can’t be undone by the antiviral,” he says.https://www.yalemedicine.org/news/13-things-to-know-paxlovid-covid-19

•    PAXLOVID is not authorized for initiation of treatment in patients requiring hospitalization due to severe or critical COVID-19.https://www.pfizer.com/news/press-release/press-release-detail/pfizer-receives-us-fda-emergency-use-authorization-novel

我没有找到试验数据,不等于没有。为什么不授权应用于重症?为什么不能救人于危难之中?我想

药商应该比我这个草民要清楚的多,授权一年多了,没有想有突破?现在试验用于长新冠( https://clinicaltrials.gov/ct2/results?cond=COVID-19&term=Paxlovid&cntry=US&state=&city=&dist=

)……。我同意医生们讲的病毒载量的问题,它对应的病毒载量是一定程度的。

为什么要5天内开始服用,这应该了解新冠的自然病程。